Adequate clinical and parasitologic cure by artemisinin combination therapies relies on the
artemisinin component and the partner drug. Polymorphisms in the Plasmodium falciparum …

Scrub typhus, caused by Orientia tsutsugamushi, is an important and neglected vector-borne
zoonotic disease with an expanding known distribution. The ecology of the disease is …

Background Plasmodium vivax infects an estimated 7 million people every year. Previously,
vivax malaria was perceived as a benign condition, particularly when compared to …

Background Chloroquine remains the mainstay of treatment for Plasmodium vivax malaria
despite increasing reports of treatment failure. We did a systematic review and meta-analysis …

Background Artemisinin-based combination therapies (ACTs) are the mainstay of the
current treatment of uncomplicated Plasmodium falciparum malaria, but ACT resistance is …

Background The availability of reliable point-of-care tests for malaria has heralded a paradigm
shift in the management of febrile illnesses away from presumptive antimalarial therapy. …

Background In the absence of definitive diagnosis, healthcare providers are likely to prescribe
empirical antibacterials to those who test negative for malaria. This problem is of critical …

Background Chagas disease (CD), caused by the parasite Trypanosoma cruzi, affects ~6–7
million people worldwide. Significant limitations still exist in our understanding of CD. …

Background Malaria causes a reduction in haemoglobin that is compounded by primaquine,
particularly in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency. The …

Background The majority of Plasmodium falciparum malaria cases in Africa are treated with
the artemisinin combination therapies artemether-lumefantrine (AL) and artesunate-…